You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰恩康(301263.SZ):公司認為“和胃整腸丸”銷售收入未來能夠維持較好的收入增速
格隆匯 07-04 08:43

格隆匯7月4日丨泰恩康(301263.SZ)近期在接待機構調研時表示,在《備忘錄》簽署後公司將盡快委派生產管理人員參與泰國李萬山的“和胃整腸丸”生產事宜,同時協助泰國李萬山對“和胃整腸丸”生產線進行改造升級。按目前的進度,公司預計今年第三季度完成產線改造升級,泰國廠家的產能在現有的基礎上將有大幅提升,迅速擴大泰國李萬山“和胃整腸丸”的產能,滿足國內市場的需求。

在解決“和胃整腸丸”的產能問題後,隨着公司加大推廣力度,公司認為“和胃整腸丸”銷售收入未來能夠維持較好的收入增速,爭取將“和胃整腸丸”打造為腸胃領域的知名頭部產品。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account